Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hiv infections | D015658 | EFO_0000764 | B20 | 7 | — | — | — | — | 7 |
Hiv | D006678 | — | — | 5 | — | — | — | — | 5 |
Neoplasms | D009369 | — | C80 | 1 | — | — | — | — | 1 |
Zika virus infection | D000071243 | — | A92.5 | 1 | — | — | — | — | 1 |
Zika virus | D000071244 | — | — | 1 | — | — | — | — | 1 |
Hiv-1 | D015497 | — | — | 1 | — | — | — | — | 1 |
Drug common name | TELRATOLIMOD |
INN | telratolimod |
Description | Telratolimod is a small molecule pharmaceutical. It is currently being investigated in clinical studies. |
Classification | Small molecule |
Drug class | immunomodulators: immunomodulators, toll-like receptor agonists |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CCCCCCCCCCCCCCCCCC(=O)NCCCCOn1c(CCCC)nc2c(N)nc3ccccc3c21 |
PDB | — |
CAS-ID | 1359993-59-1 |
RxCUI | — |
ChEMBL ID | CHEMBL4297631 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 16598XQ2BT (ChemIDplus, GSRS) |